Time to Healing, Loss of Fixation, and Loss of Alignment in Supracondylar Distal Femur Fractures Among a Geriatric Population Treated With Abaloparatide: A Double-Blind Placebo Controlled Study
Latest Information Update: 07 May 2024
Price :
$35 *
At a glance
- Drugs Abaloparatide (Primary)
- Indications Fracture; Osteoporosis
- Focus Therapeutic Use
- 30 Apr 2024 Planned End Date changed from 1 Sep 2024 to 1 Jun 2025.
- 30 Apr 2024 Planned primary completion date changed from 1 Sep 2024 to 1 Jun 2025.
- 30 Apr 2024 Planned initiation date changed from 1 Sep 2023 to 1 Jun 2024.